title: Evidence that endothelin-1 (ET-1) inhibits insulin-stimulated glucose uptake in rat adipocytes mainly through ETA receptors.
abstract: The specificity of endothelin (ET) receptors involved in the inhibition of insulin-stimulated glucose uptake (ISGU) in rat adipocytes was investigated. Adipocytes were isolated from the epididymal fat pads of Sprague-Dawley rats. To determine receptor subtypes, we used three ET isopeptides, ET-1 and ET-2, both of which are nonselective agonists, and ET-3, a selective agonist for ETC receptors, to displace [125I]ET-1 binding from the fat cells. The efficiency of displacement was ET-1 > ET-2 >> ET-3, indicating that the primary receptors involved belonged to the ETA subtype. At an equal concentration of 1 micromol/L, BQ-610, a selective ETA antagonist, displaced [125I]ET-1 from binding to fat cells, whereas IRL-1038, a selective ETB antagonist, did not. Using [3H]2-deoxy-D-1-glucose ([3H]2-DG) as a tracer in studies of glucose uptake, we found that equimolar BQ-610 completely reversed the inhibitory effect of ET-1 on ISGU, whereas IRL-1038 was ineffective. Northern blot analysis of adipocyte receptors showed abundant mRNA for ETA, but no ETB subtype. These results clearly demonstrate that ETA is the predominant receptor in rat adipocytes.
authors.affiliation: Department of Physiology, National Yang-Ming University, Taipei, Taiwan, Republic of China.
authors.forename: Y C
authors.initials: YC
authors.lastname: Lee
authors.forename: C C
authors.initials: CC
authors.lastname: Juan
authors.forename: V S
authors.initials: VS
authors.lastname: Fang
authors.forename: Y P
authors.initials: YP
authors.lastname: Hsu
authors.forename: S H
authors.initials: SH
authors.lastname: Lin
authors.forename: C F
authors.initials: CF
authors.lastname: Kwok
authors.forename: L T
authors.initials: LT
authors.lastname: Ho
mesh_terms: D017667:Adipocytes / Q000187:drug effects*; D000818:Animals; D001667:Binding, Competitive; D019332:Endothelin-1 / Q000494:pharmacology*; D019333:Endothelin-2 / Q000494:pharmacology; D019334:Endothelin-3 / Q000494:pharmacology; D016232:Endothelins / Q000494:pharmacology; D005947:Glucose / Q000493:pharmacokinetics*; D007328:Insulin / Q000494:pharmacology*; D007329:Insulin Antagonists / Q000494:pharmacology; D008297:Male; D009842:Oligopeptides / Q000494:pharmacology; D010446:Peptide Fragments / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D019332:Endothelin-1; D019333:Endothelin-2; D019334:Endothelin-3; D016232:Endothelins; D007328:Insulin; D007329:Insulin Antagonists; D009842:Oligopeptides; D010446:Peptide Fragments; D012333:RNA, Messenger; C087220:BQ 610; C077420:Cys(11)-Cys(15)-endothelin-1 (11-21); D005947:Glucose